The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Solpa-Plus with Caffeine Soluble Tablets Paracetamol 500 mg Codeine Phosphate Hemihydrate 12.8 mg Caffeine 30 mg



Chefaro Ireland DACPA1186/011/004

Main Information

Trade NameSolpa-Plus with Caffeine Soluble Tablets Paracetamol 500 mg Codeine Phosphate Hemihydrate 12.8 mg Caffeine 30 mg
Active SubstancesParacetamol
Codeine phosphate hemihydrate
Caffeine
Dosage FormEffervescent tablet
Licence HolderChefaro Ireland DAC
Licence NumberPA1186/011/004

Group Information

ATC CodeN02AJ Opioids in combination with non-opioid analgesics
N02AJ06 codeine and paracetamol

Status

License statusAuthorised
Licence Issued10/03/2017
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceRetail sale through pharmacies only in blister packs containing not more than 24 unit dosage forms. For codeine: maximum dose equivalent of 20 mg. Packs containing more than 24 unit dosage forms are prescription only.
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back